( I-ASEAN, i-Association of Southeast Asian Nations, kunye neMalaysia, i-Indonesia, iThailand, iiPhilippines, iSingapore, iBrunei, iVietnam, iLaos, iMyanmar neCambodia, yeyona ngongoma iphambili yengxelo yesivumelwano saseBangkok ekhutshwe kunyaka ophelileyo, okanye inokubonelela unyango losulelo lwe-Helicobacter pylori. Ezinye izimvo. )

Usulelo lwe-Helicobacter pylori (Hp) luhlala luguquka, kwaye iingcali kwintsimi yokugaya ziye zacinga malunga neyona ndlela yonyango.Unyango losulelo lwe-Hp kumazwe ase-ASEAN: INkomfa ye-Bangkok Consensus yadibanisa iqela leengcali eziphambili ezivela kummandla ukuba zihlolisise kwaye zivavanye usulelo lwe-Hp ngokwemiqathango yeklinikhi, kunye nokuphuhlisa iingxelo zokuvumelana, iingcebiso, kunye neengcebiso zonyango lweklinikhi losulelo lwe-Hp kwi-ASEAN. amazwe.INkomfa ye-ASEAN Consensus yayiye kwiingcali zamazwe ngamazwe ze-34 ezivela kumazwe angamalungu e-10 ASEAN kunye neJapan, iTaiwan kunye ne-United States.

Intlanganiso ibigxile kwizihloko ezine:

(I) i-epidemiology kunye namakhonkco ezifo;

(II) iindlela zokuxilonga;

(III) izimvo zonyango;

(IV) ukulandelela emva kokupheliswa.

Ingxelo yemvumelwano

Inkcazo 1:I-1a: Ukusuleleka kwe-Hp kwandisa umngcipheko weempawu ze-dyspeptic.(Inqanaba loBungqina: liPhakamileyo; iNqanaba elicetyiswayo: N/A);I-1b: Zonke izigulane ezine-dyspepsia kufuneka zihlolwe kwaye ziphathwe ngokusuleleka kwi-Hp.(Inqanaba lobungqina: liphezulu; inqanaba elicetyiswayo: elomeleleyo)

Inkcazo 2:Ngenxa yokuba ukusetyenziswa kosulelo lwe-Hp kunye / okanye i-non-steroidal anti-inflammatory drugs (NSAIDs) ihambelana kakhulu nezilonda ze-peptic, unyango oluphambili lwezilonda ze-peptic kukuphelisa i-Hp kunye / okanye ukuyeka ukusetyenziswa kwe-NSAIDs.(Inqanaba lobungqina: liphezulu; inqanaba elicetyiswayo: elomeleleyo)

Inkcazo 3:Izehlo zeminyaka yobudala zomhlaza wesisu kumazwe ase-ASEAN yi-3.0 ukuya kwi-23.7 kwi-100,000 yomntu-iminyaka.Kumazwe amaninzi e-ASEAN, umhlaza wesisu uhlala ungoyena nobangela we-10 wokufa komhlaza.I-gastric mucosa-associated lymphoid tissue lymphoma (isisu se-MALT lymphoma) inqabile kakhulu.(Inqanaba lobungqina: liphezulu; inqanaba elicetyiswayo: N/A)

Inkcazo 4:Ukupheliswa kwe-Hp kunokunciphisa umngcipheko womhlaza wesisu, kwaye amalungu osapho lwezigulane zomhlaza wesisu kufuneka ahlolwe kwaye anyangelwe i-Hp.(Inqanaba lobungqina: liphezulu; inqanaba elicetyiswayo: elomeleleyo)

Inkcazo 5:Izigulane ezine-GAstric MALT lymphoma kufuneka zipheliswe kwi-Hp.(Inqanaba lobungqina: liphezulu; inqanaba elicetyiswayo: elomeleleyo) 

Inkcazo 6:I-6a: Ngokusekelwe kumthwalo wentlalo yesi sifo, kuyindleko yokuqhuba ukuhlolwa koluntu lwe-Hp ngovavanyo olungenakuthintelwa ukukhusela ukupheliswa komhlaza wesisu.(Inqanaba lobungqina: liphezulu; inqanaba elicetyiswayo: buthathaka)

I-6b: Okwangoku, kumazwe amaninzi e-ASEAN, ukuhlolwa komhlaza wesisu soluntu nge-endoscopy akunakwenzeka.(Inqanaba loBungqina: Phakathi; Inqanaba elicetyiswayo: Ubuthathaka)

Ingxelo yesi-7:Kumazwe ase-ASEAN, iziphumo ezahlukeneyo zosulelo lwe-Hp zichongwa yintsebenziswano phakathi kwezinto ezinobungozi be-Hp, umkhosi kunye nezinto zokusingqongileyo.(Inqanaba lobungqina: liphezulu; inqanaba elicetyiswayo: N/A)

Inkcazo 8:Zonke izigulana ezinezilonda ezinobungozi zomhlaza wesisu kufuneka zichongwe kwaye zinyangwe nge-Hp, kwaye zicwangcise umngcipheko womhlaza wesisu.(Inqanaba lobungqina: liphezulu; ukukala okucetyiswayo: okunamandla)

Indlela yokuxilongwa kweHp

Inkcazo 9:Iindlela zokuxilonga ze-Hp kummandla we-ASEAN zibandakanya: uvavanyo lokuphefumula urea, uvavanyo lwe-fecal antigen (i-monoclonal) kunye novavanyo oluqinisekisiweyo lwasekuhlaleni olukhawulezayo lwe-urease (RUT)/histology.Ukhetho lwendlela yokubona luxhomekeke kukhetho lwesigulana, ukufumaneka, kunye neendleko.(Inqanaba lobungqina: liphezulu; inqanaba elicetyiswayo: elomeleleyo) 

Inkcazo 10:Ukufunyanwa kwe-Hp esekelwe kwi-Biopsy kufuneka kwenziwe kwizigulane ezithatha i-gastroscopy.(Inqanaba loBungqina: Phakathi; iNqanaba elicetyiswayo: Linamandla)

Inkcazo 11:Ukufunyanwa kwe-Hp proton pump inhibitor (PPI) kunqanyulwe ubuncinane kwiiveki ezi-2;Amayeza okubulala iintsholongwane ayayekwa kangangeeveki ezi-4 ubuncinane.(Inqanaba lobungqina: liphezulu; ukukala okucetyiswayo: okunamandla)

Inkcazo 12:Xa unyango lwe-PPI olude lufuneka, kuyacetyiswa ukuba kubonwe i-Hp kwizigulane ezine-gastroesophageal reflux disease (GERD).(Inqanaba loBungqina: Phakathi; Umlinganiselo oCetyisiweyo: Owomeleleyo)

Inkcazo 13:Izigulane ezifuna unyango lwexesha elide kunye ne-NSAID kufuneka zivavanywe kwaye ziphathwe i-Hp.(Inqanaba lobungqina: liphezulu; inqanaba elicetyiswayo: elomeleleyo) 

Inkcazo 14:Kwizigulana ezophayo kunye ne-Hp engalunganga ye-biopsy yokuqala, usulelo kufuneka luqinisekiswe ngovavanyo olulandelayo lwe-Hp.(Inqanaba loBungqina: Phakathi; iNqanaba elicetyiswayo: Linamandla)

Inkcazo 15:Uvavanyo lokuphefumula kwe-urea lolona khetho lungcono emva kokupheliswa kwe-Hp, kwaye uvavanyo lwe-fecal antigen lunokusetyenziswa njengenye indlela.Uvavanyo kufuneka lwenziwe ubuncinane kwiiveki ezi-4 emva kokuphela konyango lokuphelisa.Ukuba i-gastroscope isetyenziswe, i-biopsy inokwenziwa.(Inqanaba lobungqina: liphezulu; inqanaba elicetyiswayo: elomeleleyo)

Inkcazo 16:Kucetyiswa ukuba amagunya ezempilo esizwe kumazwe ase-ASEAN abuyisele i-Hp ngovavanyo lokuxilonga kunye nonyango.(Inqanaba lobungqina: liphantsi; inqanaba elicetyiswayo: olomeleleyo)